WO2023248161 - SOLID STATE FORMS OF DIBUPRENORPHINE ETHYL ETHER AND PROCESS FOR PREPARATION THEREOF
National phase entry:
Publication Number
WO/2023/248161
Publication Date
28.12.2023
International Application No.
PCT/IB2023/056430
International Filing Date
21.06.2023
Title **
[English]
SOLID STATE FORMS OF DIBUPRENORPHINE ETHYL ETHER AND PROCESS FOR PREPARATION THEREOF
[French]
FORMES À L'ÉTAT SOLIDE D'ÉTHER ÉTHYLIQUE DE DIBUPRÉNORPHINE ET LEUR PROCÉDÉ DE PRÉPARATION
Applicants **
TEVA CZECH INDUSTRIES S.R.O
Inventors
PRZECZKOVA, Zuzana
BENYSEK BARTOVA, Adela
KOLESA, Pavel
BITTNER, Leopold
JEGOROV, Alexandr
Priority Data
63/354,282
22.06.2022
US
63/426,400
18.11.2022
US
63/468,177
22.05.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2030 | |
| EPO | Filing, Examination, Granting | 8309 | |
| Japan | Filing, Examination, Granting | 1852 | |
| South Korea | Filing, Examination, Granting | 1418 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,349
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Solid state forms of Dibuprenorphine-ethyl-ether and Dibuprenorphine-ethyl-ether 2HCl are provided, as well as processes for the preparation thereof, and pharmaceutical compositions thereof.[French]
L'invention concerne des formes à l'état solide de dibuprénorphine-éthyl-éther et de dibuprénorphine-éthyl-éther 2HCl, ainsi que des procédés pour leur préparation, et des compositions pharmaceutiques associées.